DavidH.PriestMDMPH

Infectious Disease • Winston-Salem, NC

HIV/AIDS Medicine, Mycobacterial Disease

SVP, Chief Safety, Quality, and Epidemiology Officer Novant Health

Join to view full profile

Dr. Priest is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Priest's full profile

Already have an account?

Office
1381 Westgate Center Dr
Winston-Salem, NC 27103
Phone+1 336-718-0440

Fax+1 336-718-0441
Is this information wrong?

Education & Training

University of FloridaMPH, Public Health Practice, 2014 - 2017
Vanderbilt University Medical CenterFellowship, Infectious Disease, 2002 - 2004
Wake Forest University School of MedicineResidency, Internal Medicine, 1999 - 2002
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1999
Wake Forest UniversityB.S, Biology, 1991 - 1995

Certifications & Licensure

NC State Medical License 1999 - 2025
VA State Medical License 2004 - 2006
TN State Medical License 2002 - 2005
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

Fellow IDSA, 2018
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Outstanding Infectious Diseases Fellow Vanderbilt University, 2004
Alpha Omega Alpha, Medical Honor Society Beta Chapter of North Carolina, 2003
Golden Key National Honor Society 1995
Scholarship Recipient Marine Corps Wives of Washington, D.C, 1991
Eagle Scout Award 1988
Alpha Epsilon Delta Premedical Honor Society
Join now to see all

Publications & Presentations

PubMed

Screening for hepatitis C as part of an opioid stewardship quality improvement initiative: Identifying infected patients and analyzing linkage to care.
DeCamillis, R., Hekman, A., Priest, D.> ;Clinical Liver Disease. 2024 Jan 25
Reply to McCreery et al.
Steven W. Johnson, Shannon V Brown, David H. Priest> ;Clinical Infectious Diseases. 2020 Oct 23
32 citations
Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure.
Steven W. Johnson, Shannon V Brown, David H. Priest> ;Clinical Infectious Diseases. 2020 Aug 22
A regional collaboration between competing healthcare systems to establish influenza season parameters.
David H. Priest, Susan L. DeCamp-Freeze, Cynthia Snider, Melissa Morgan, Misty D. Garner, Laurence B. Givner, Catherine L. Passaretti, Andrea B. McQuaigue> ;Infection Control and Hospital Epidemiology. 2019 Feb 1
1 citations
Secondary immune thrombocytopenia (ITP) as an initial presentation of Whipple’s disease
David H. Priest, Thomas H. Grote, Sallie L. Staley, William S. Berger, Elizabeth S. Norman, Brian S. Smith> ;Idcases. 2017 Jun 28
9 citations
Effectiveness of ledipasvir/sofosbuvir in real-world patients with chronic hepatitis C: a collaborative treatment approach
Steven W. Johnson, Shelby R. Ammirati, Charles E. Hartis, Stephen F. Weber, Michael R. Morgan, Timothy A. Darnell, Adwait Silwal, Holly N. Schmidlin, David H. Priest> ;International Journal of Antimicrobial Agents. 2017 Jun 1
3 citations
Loiasis in US Traveler Returning from Bioko Island, Equatorial Guinea, 2016.
David H Priest, Thomas B. Nutman> ;Emerging Infectious Diseases. 2017 Jan 1
2 citations
Curing the historically incurable: treatment success with ledipasvir/sofosbuvir for chronic hepatitis C virus in a heavily treatment-experienced individual.
Steven W. Johnson, M. M. Davis, L. M. Stever, D. H. Priest> ;Journal of Clinical Pharmacy and Therapeutics. 2016 Sep 27
102 citations
Hematogenous vertebral osteomyelitis due to Staphylococcus aureus in the adult : Clinical features and therapeutic outcomes
David H. Priest, James E. Peacock> ;Southern Medical Journal. 2005 Sep 1
24 citations
Use of Intermittent Rifampin and Pyrazinamide Therapy for Latent Tuberculosis Infection in a Targeted Tuberculin Testing Program
David H. Priest, Louis F. Vossel, Elizabeth A. Sherfy, Debbie P. Hoy, Connie A. Haley> ;Clinical Infectious Diseases. 2004 Dec 15
3 citations
Infectious Disease Images on the World Wide Web
David H. Priest, Stephen J. Williams> ;Clinical Infectious Diseases. 2004 Feb 15
Join now to see all

Journal Articles

Bamlanivimab for the prevention of hospitalizations and emergency department visits in SARS-CoV-2-positive patients in a regional health care system
Priest et al, Infectious Diseases in Clinical Practice, 3/2022

Press Mentions

XBB.1.5, the Latest COVID Variant, Spreads Across USJanuary 11th, 2023
'It's Not Too Late' | Doctors Urging Flu Vaccines to Prevent Heart Attack or StrokeDecember 10th, 2022
Doctors with Novant Health Give Update on COVID, Flu, and RSVDecember 6th, 2022
Join now to see all